BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19967801)

  • 1. Biologics: The quest for a universal antidote.
    Flight MH
    Nat Rev Drug Discov; 2009 Dec; 8(12):934. PubMed ID: 19967801
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidote control of aptamer therapeutics: the road to a safer class of drug agents.
    Bompiani KM; Woodruff RS; Becker RC; Nimjee SM; Sullenger BA
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1924-34. PubMed ID: 22352726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of universal antidotes to control aptamer activity.
    Oney S; Lam RT; Bompiani KM; Blake CM; Quick G; Heidel JD; Liu JY; Mack BC; Davis ME; Leong KW; Sullenger BA
    Nat Med; 2009 Oct; 15(10):1224-8. PubMed ID: 19801990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity.
    Dyke CK; Steinhubl SR; Kleiman NS; Cannon RO; Aberle LG; Lin M; Myles SK; Melloni C; Harrington RA; Alexander JH; Becker RC; Rusconi CP
    Circulation; 2006 Dec; 114(23):2490-7. PubMed ID: 17101847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamers: the emerging class of future anticoagulation for vascular disease.
    Kuliczkowski W; Floyd J; Malinin A; Serebruany V
    Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):503-7. PubMed ID: 20397824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxocobalamin as a cyanide antidote.
    DesLauriers CA; Burda AM; Wahl M
    Am J Ther; 2006; 13(2):161-5. PubMed ID: 16645433
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic applications of aptamers.
    Kaur G; Roy I
    Expert Opin Investig Drugs; 2008 Jan; 17(1):43-60. PubMed ID: 18095918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Old antidotes, new antidotes, and a 'universal antidote': what should we be using for pediatric poisoning?
    Liebelt EL
    Curr Opin Pediatr; 2007 Apr; 19(2):199-200. PubMed ID: 17496765
    [No Abstract]   [Full Text] [Related]  

  • 9. An anticoagulant with light-triggered antidote activity.
    Heckel A; Buff MC; Raddatz MS; Müller J; Pötzsch B; Mayer G
    Angew Chem Int Ed Engl; 2006 Oct; 45(40):6748-50. PubMed ID: 16983715
    [No Abstract]   [Full Text] [Related]  

  • 10. Who gets antidotes? choosing the chosen few.
    Buckley NA; Dawson AH; Juurlink DN; Isbister GK
    Br J Clin Pharmacol; 2016 Mar; 81(3):402-7. PubMed ID: 26816206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fomepizole as an antidote for ethylene glycol poisoning.
    Battistella M
    Ann Pharmacother; 2002 Jun; 36(6):1085-9. PubMed ID: 12022913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antidotes in clinical toxicology].
    Hruby K
    Med Klin Intensivmed Notfmed; 2013 Sep; 108(6):465-70. PubMed ID: 23921789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticyan--a new highly effective antidote in cyanide poisoning].
    Trinus FP; Chubenko AV; Pedchenko TV
    Lik Sprava; 1995; (5-6):175-6. PubMed ID: 8630797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New High-Affinity Thrombin Aptamers for Advancing Coagulation Therapy: Balancing Thrombin Inhibition for Clot Prevention and Effective Bleeding Management with Antidote.
    Ayass MA; Griko N; Pashkov V; Tripathi T; Zhang J; Ramankutty Nair R; Okyay T; Zhu K; Abi-Mosleh L
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New antidotes in toxicology].
    Bédry R
    Rev Prat; 2008 Apr; 58(8):844-8. PubMed ID: 18630821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated charcoal vs. "universal antidote" as an antidote for poisons.
    Picchioni AL; Chin L; Verhulst HL; Dieterle B
    Toxicol Appl Pharmacol; 1966 May; 8(3):447-54. PubMed ID: 5961560
    [No Abstract]   [Full Text] [Related]  

  • 17. Fomepizole versus ethanol in the treatment of acute methanol poisoning: Comparison of clinical effectiveness in a mass poisoning outbreak.
    Zakharov S; Pelclova D; Navratil T; Belacek J; Komarc M; Eddleston M; Hovda KE
    Clin Toxicol (Phila); 2015; 53(8):797-806. PubMed ID: 26109326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic acid therapeutics: a focus on the development of aptamers.
    Jain S; Kaur J; Prasad S; Roy I
    Expert Opin Drug Discov; 2021 Mar; 16(3):255-274. PubMed ID: 32990095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of poisoning by binding of poisons in the gastrointestinal tract: charcoal of "universal antidote"?].
    Henschler D; Kreutzer P
    Dtsch Med Wochenschr; 1966 Dec; 91(50):2241-8. PubMed ID: 5924249
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antidote use in a pediatric emergency department].
    Martínez Sánchez L; Almario Hernández AF; Escuredo Argullós L; Maçao P; Trenchs Sainz de la Maza V; Luaces Cubells C
    An Pediatr (Barc); 2014 Oct; 81(4):220-5. PubMed ID: 24439102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.